The C19 Immunity Study

The C19 Immunity Study is led by scientists at the Bruyère Research Institute and the University of Ottawa, with collaborators from the University of British Columbia, McGill University, and the

University of Toronto.


The goal of this study is to build a better understanding of how widespread COVID-19 is in Canada among our most vulnerable and high-risk populations, as well as the effectiveness and safety of currently approved COVID-19 vaccines.